Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results
07 nov. 2023 16h00 HE
|
Standard BioTools Inc.
Year-to-date revenue growth, gross margin expansion and operating expense reduction are testament to continued execution against financial objectivesPlanned merger with SomaLogic activates strategic...
Standard BioTools to Present at the Jefferies London Healthcare Conference
02 nov. 2023 08h30 HE
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
Standard BioTools Announces Conference Call and Webcast of Third Quarter 2023 Financial Results on November 7, 2023
25 oct. 2023 08h30 HE
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools
04 oct. 2023 08h00 HE
|
Standard BioTools Inc.; SomaLogic, Inc.
Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of multi-omic technologies with the highest throughput and highest...
Standard BioTools Reports Second Quarter 2023 Financial Results
08 août 2023 16h05 HE
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) (“Standard BioTools”, or the “Company”), driven by a bold purpose – Unleashing tools to accelerate...
Standard BioTools to Participate in Upcoming Investor Conferences
26 juil. 2023 16h05 HE
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
Standard BioTools Announces Conference Call and Webcast for Second Quarter 2023 Financial Results
25 juil. 2023 16h05 HE
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
Standard BioTools to Participate in Upcoming Investor Conferences
14 juin 2023 07h30 HE
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., June 14, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
Standard BioTools to Present at the Jefferies Healthcare Conference
25 mai 2023 16h05 HE
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
Standard BioTools Announces NGS Library Preparation as an Upgrade on the X9 High-Throughput Genomics System
18 mai 2023 07h30 HE
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...